Additional evidence of the involvement of MET in the landscape of drug resistance is supported by a study conducted by Min and colleagues, which demonstrated that MET signaling activation is essential for GBM stem cells and that METet inhibition suppresses tumor growth and invasiveness [70]. Here, MET is linked to glioblastoma.